GlassScriptPhysician profile
Dennis Park
NPI 1881600328
$9,764.35
in general payments reported to CMS, 2019-2025
26 companies · $1,311 in 2025
The $1,311 reported for 2025 was more than what 91% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,019 · 2020: $237 · 2021: $245 · 2022: $944 · 2023: $160 · 2024: $5,849 · 2025: $1,311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,904 · Food and Beverage: $2,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,904.28 |
| Food and Beverage | $2,415.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $7,715.78 | 2019-2025 | Mako, Blueprint Patient Specific Instrumentation, Pangea |
| Pacira Therapeutics, INC. | $280.50 | 2019-2021 | |
| Evolution Surgical, INC | $189.67 | 2021-2025 | |
| Endo Pharmaceuticals INC. | $180.95 | 2019-2020 | |
| Smith+Nephew, INC. | $171.15 | 2019-2021 | |
| Bioventus LLC | $149.10 | 2019-2024 | Exogen Ultrasound Bone Healing System, Gelsyn-3 |
| Ferring Pharmaceuticals INC. | $122.13 | 2019-2024 | Euflexxa |
| Fidia Pharma USA INC. | $116.50 | 2020-2024 | Triluron |
| Horizon Therapeutics Plc | $103.81 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $91.15 | 2019 | |
| Sanofi-Aventis U.S. LLC | $70.92 | 2019-2020 | |
| Pacira Pharmaceuticals Incorporated | $67.87 | 2022-2024 | Zilretta, Iovera |
| Orthofix Medical, INC. | $58.79 | 2024-2025 | Physio-Stim, Accelstim |
| Depuy Synthes Sales INC. | $58.37 | 2021-2025 | Monovisc, Orthovisc |
| Assertio Therapeutics, INC. | $52.94 | 2019 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.96 | 2019 | |
| Amgen INC. | $48.35 | 2019 | |
| Zimmer Biomet Holdings, INC. | $42.59 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $37.94 | 2025 | |
| Avanos Medical | $37.14 | 2021-2024 | On-Q* Pump and Accessories |
| Abbott Laboratories | $24.39 | 2022 | |
| Medtronic, INC. | $22.93 | 2024 | Aquamantys(Tm) |
| Boston Scientific Corporation | $22.23 | 2019 | |
| Davol INC. | $20.59 | 2023 | |
| Shionogi INC | $14.22 | 2019 | |
| Kaleo, INC. | $12.38 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dennis Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.